Elke Kleemann und Thomas Schmehl - Info zur Person

(1 - 8 von 10

)

Iloprost-Containing Liposomes for Aerosol Application in Pulmonary...

www.proquest.com

von E Kleemann · · Zitiert von: 107 — Elke Kleemann,1,3 Thomas Schmehl,2 Tobias Gessler,2 Udo Bakowsky,1 Thomas Kissel,1 and Werner Seeger2. Received April 11, 2006; accepted July 28, 2006; ... › openview › 1.pdf

Iloprost-Containing Liposomes for Aerosol Application in Pulmonary...

link.springer.com

Elke Kleemann ,; Thomas Schmehl , ...

Effect of PEGylation on the stability of liposomes during ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von S Anabousi · · Zitiert von: 56 — Authors. Samah Anabousi , Elke Kleemann, Udo Bakowsky, Thomas Kissel, Thomas Schmehl, Tobias Gessler, Werner Seeger, Claus-Michael Lehr, Carsten Ehrhardt ... › ...

Enhanced gene expression and reduced toxicity in mice ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von E Kleemann · · Zitiert von: 29 — Elke Kleemann , Norman Jekel, Lea Ann Dailey, Susanne Roesler, Ludger Fink, Norbert Weissmann, Ralph Schermuly, Tobias Gessler, Thomas Schmehl, Clive J ...

Iloprost-containing liposomes for aerosol application in ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von E Kleemann · · Zitiert von: 118 — Authors. Elke Kleemann , Thomas Schmehl, Tobias Gessler, Udo Bakowsky, Thomas Kissel, Werner Seeger. Affiliation. 1 Department of Pharmaceutics and ... › ...

Iloprost-Containing Liposomes for Aerosol Application in Pulmonary...

www.proquest.com

Elke Kleemann,1,3 Thomas Schmehl,2 Tobias Gessler,2 Udo Bakowsky,1 Thomas Kissel,1 and Werner Seeger2. Received April 11, 2006; accepted July 28, 2006; ...